ATE416783T1 - Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen - Google Patents
Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomenInfo
- Publication number
- ATE416783T1 ATE416783T1 AT03708393T AT03708393T ATE416783T1 AT E416783 T1 ATE416783 T1 AT E416783T1 AT 03708393 T AT03708393 T AT 03708393T AT 03708393 T AT03708393 T AT 03708393T AT E416783 T1 ATE416783 T1 AT E416783T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- chorionic gonadotropin
- human chorionic
- endometriosis
- symptoms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2003/001066 WO2004069271A1 (en) | 2003-02-07 | 2003-02-07 | Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE416783T1 true ATE416783T1 (de) | 2008-12-15 |
Family
ID=32843795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03708393T ATE416783T1 (de) | 2003-02-07 | 2003-02-07 | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060258568A1 (de) |
EP (1) | EP1596881B1 (de) |
AT (1) | ATE416783T1 (de) |
AU (1) | AU2003212569A1 (de) |
CA (1) | CA2515297A1 (de) |
DE (1) | DE60325275D1 (de) |
WO (1) | WO2004069271A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080306034A1 (en) * | 2007-06-11 | 2008-12-11 | Juneau Biosciences, Llc | Method of Administering a Therapeutic |
US8680086B2 (en) * | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
US20150290293A1 (en) * | 2011-04-15 | 2015-10-15 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using hcg |
US20120265129A1 (en) | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
BR112015008753A2 (pt) | 2012-10-18 | 2017-07-04 | Neuralight Hd Llc | tratamento de depressão e ptsd |
WO2016077565A2 (en) * | 2014-11-12 | 2016-05-19 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using hcg |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4196123A (en) * | 1978-11-20 | 1980-04-01 | Eugenia Rosemberg | Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same |
ZA845550B (en) * | 1983-08-09 | 1986-03-26 | American Home Prod | Treatment of endometriosis |
EP1022027A1 (de) * | 1999-01-22 | 2000-07-26 | Applied Research Systems ARS Holding N.V. | Antagonisten von Tumornecrosefaktor und ihre Verwendungen gegen Endometriose |
US6284262B1 (en) * | 1999-01-26 | 2001-09-04 | Virgil A. Place | Compact dosage unit for buccal administration of a pharmacologically active agent |
WO2000067778A1 (en) * | 1999-05-07 | 2000-11-16 | Applied Research Systems Ars Holding N.V. | Gonadotrophins |
AR036592A1 (es) * | 2001-09-12 | 2004-09-22 | Applied Research Systems | Uso de gch en la hiperestimulacion ovarica controlada |
-
2003
- 2003-02-07 EP EP03708393A patent/EP1596881B1/de not_active Expired - Lifetime
- 2003-02-07 US US10/544,856 patent/US20060258568A1/en not_active Abandoned
- 2003-02-07 DE DE60325275T patent/DE60325275D1/de not_active Expired - Fee Related
- 2003-02-07 AT AT03708393T patent/ATE416783T1/de not_active IP Right Cessation
- 2003-02-07 AU AU2003212569A patent/AU2003212569A1/en not_active Abandoned
- 2003-02-07 CA CA002515297A patent/CA2515297A1/en not_active Abandoned
- 2003-02-07 WO PCT/IB2003/001066 patent/WO2004069271A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
DE60325275D1 (de) | 2009-01-22 |
WO2004069271A1 (en) | 2004-08-19 |
EP1596881B1 (de) | 2008-12-10 |
US20060258568A1 (en) | 2006-11-16 |
AU2003212569A1 (en) | 2004-08-30 |
CA2515297A1 (en) | 2004-08-19 |
EP1596881A1 (de) | 2005-11-23 |
AU2003212569A8 (en) | 2004-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
NO20055741L (no) | Nye kjemiske forbindelser | |
ATE368034T1 (de) | Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase | |
ATE517896T1 (de) | P38-kinase-inhibitoren | |
DE602005011279D1 (de) | Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen | |
DE60332433D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
DE60332604D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
ATE464303T1 (de) | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen | |
ATE395052T1 (de) | Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes | |
GB0402143D0 (en) | Novel compounds | |
NO20065859L (no) | Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser | |
DE60204951D1 (de) | Ccr5 antagonisten verwendbar für die behandlung von aids | |
CY1107204T1 (el) | Πιπεραζινοβενζοθειαζολια ως ουσιες για την θεραπευτικη αντιμετωπιση εγκεφαλικων ισχαιμικων διαταραχων ή διαταραχων του κνς | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
DE602004023762D1 (de) | Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren | |
SE0302304D0 (sv) | Novel compounds | |
BR0209541A (pt) | Uso das imidazotriazinonas 2-fenil-substituìdas | |
ATE416783T1 (de) | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen | |
DE60101559D1 (de) | Benutzung von comt-inhibitoren als analgetika | |
GB0402138D0 (en) | Novel compounds | |
EA200300844A1 (ru) | Использование ингибиторов il-18 для лечения и/или профилактики заболевания сердца | |
DE60334556D1 (de) | Chorionic gonadotropin zur Behandlung des chronischen Schmerzsyndroms des Beckens | |
DE602004019541D1 (de) | Cycloalkyläbü kondensierte indole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |